Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Nannan, Chu"'
Autor:
Ying Ding, Nannan Chu, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/ef9b56e1f6164aa2b58e84d08d94d9fd
Autor:
Ying Ding, Nannan Chu, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: The main purpose of this study was to evaluate the pharmacokinetics, bioequivalence, and safety properties between a new generic and a brand reference formulation of esomeprazole enteric-coated tablets 20 mg in healthy Chinese subjects und
Externí odkaz:
https://doaj.org/article/24c0d4cd04334bc8ade86943b688acd1
Autor:
Kai Huang, Yunfei Shi, Nannan Chu, Linling Que, Ying Ding, Zhenzhong Qian, Wei Qin, Xianghong Gu, Jiakun Wang, Zhiwei Zhang, Jianguo Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: This study was performed to investigate the effect of food on the pharmacokinetics (PK) of WXFL10203614 in healthy Chinese subjects.Methods: This was a randomized, open-label, single-dose, two-treatment (fed vs fasted), two-period, two-seq
Externí odkaz:
https://doaj.org/article/3afd5acbae14491a926baa7f5a396b76
Autor:
Kai Huang, Ying Ding, Linling Que, Nannan Chu, Yunfei Shi, Zhenzhong Qian, Wei Qin, Yuanxin Chen, Xianghong Gu, Jiakun Wang, Zhiwei Zhang, Jianguo Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: This study was conducted to investigate the safety, tolerability and pharmacokinetics (PK) of WXFL10203614 after single and multiple oral doses in healthy Chinese subjects.Methods: A single-center, randomized, double-blind, placebo-control
Externí odkaz:
https://doaj.org/article/ebbde913409e4571b21f893d9ed63197
Autor:
Kai Huang, Linling Que, Ying Ding, Nannan Chu, Zhenzhong Qian, Yunfei Shi, Wei Qin, Zhenni Li, Yuanxin Chen, Xianghong Gu, Jiakun Wang, Lin Zhang, Jisheng Zhang, Xiangyang Zhu, Yongmin Yang, Yuan Tang, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objective: This study was conducted to compare the pharmacokinetics, safety and immunogenicity of HOT-1010 with bevacizumab (Avastin®) in Chinese healthy male subjects.Methods: A single-center, randomized, double-blind, single-dose, parallel trial w
Externí odkaz:
https://doaj.org/article/32b04462331c4005ae0a3ed670018440
Autor:
Nannan Chu, Ying Ding, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology. 14
Objective: The main purpose of this study was to evaluate the pharmacokinetics, bioequivalence, and safety properties between a new generic and a brand reference formulation of esomeprazole enteric-coated tablets 20 mg in healthy Chinese subjects und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d22fb7b5bc5bb56ebc88d68ef7561231
https://doi.org/10.3389/fphar.2023.1169103
https://doi.org/10.3389/fphar.2023.1169103
Autor:
Kai, Huang, Nannan, Chu, Ying, Ding, Linglin, Que, Zhenzhong, Qian, Yunfei, Shi, Wei, Qin, Qing, He
Publikováno v:
Clinical Pharmacology in Drug Development. 11:1116-1123
This study aimed to compare the pharmacokinetics, safety, and immunogenicity of the prefilled syringe (PFS) with lyophilized (LYO) recombinant human tumor necrosis factor-α receptor II:lgG Fc fusion protein (rhTNFR:Fc) in healthy Chinese male subjec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5121f081377f4b73fdfa5f60f2fe9706
https://doi.org/10.1002/cpdd.1091
https://doi.org/10.1002/cpdd.1091
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:1225-1231
Henagliflozin is a novel selective sodium-glucose co-transporter 2 (SGLT2) inhibitor with similar inhibitory effect to ertugliflozin. Glimepiride is widely used to treat type 2 diabetes mellitus (T2DM) with few cardiovascular side effects. In the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab8012c4867b2a3a81621f513efc3be
https://doi.org/10.1111/jcpt.13659
https://doi.org/10.1111/jcpt.13659
Autor:
Ying Ding, Nannan Chu, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology; 2023, p1-9, 9p
Autor:
Yuanxing Chen, Nannan Chu, Zhenzhong Qian, Linling Que, Wei Qin, Kai Huang, Qing He, Ying Ding, Jisheng Zhang
Publikováno v:
Journal of Pharmacy and Pharmacology. 73:388-397
Objectives To determine the kinetics of the formation of 10,11-dihydro-10-hydroxy-carbazepine (MHD)-O-glucuronide in human liver microsomes (HLMs), human intestine microsomes (HIMs), human kidney microsomes (HKMs) and recombinant human UDP-glucuronos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7656ce6c92437a6966982156a424cb5
https://doi.org/10.1093/jpp/rgaa059
https://doi.org/10.1093/jpp/rgaa059